These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21698655)

  • 1. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.
    Katsila T; Siskos AP; Tamvakopoulos C
    Mass Spectrom Rev; 2012; 31(1):110-33. PubMed ID: 21698655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of MALDI TOF MS in biopharmaceutical research.
    Kafka AP; Kleffmann T; Rades T; McDowell A
    Int J Pharm; 2011 Sep; 417(1-2):70-82. PubMed ID: 21147205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative liquid chromatography tandem mass spectrometry analysis of macromolecules using signature peptides in biological fluids.
    Halquist MS; Thomas Karnes H
    Biomed Chromatogr; 2011 Jan; 25(1-2):47-58. PubMed ID: 21154882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the immunogenicity of a protein drug using equilibrium dialysis and liquid chromatography tandem mass spectrometry detection.
    Ji QC; Rodila R; Morgan SJ; Humerickhouse RA; El-Shourbagy TA
    Anal Chem; 2005 Sep; 77(17):5529-33. PubMed ID: 16131062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry for the quantification of bioactive peptides in biological fluids.
    Tamvakopoulos C
    Mass Spectrom Rev; 2007; 26(3):389-402. PubMed ID: 17160998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M; Bessire A; Song W; Huntington C; Groeber E
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.
    Ewles M; Goodwin L
    Bioanalysis; 2011 Jun; 3(12):1379-97. PubMed ID: 21679032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
    Nassar AE; Talaat RE; Kamel AM
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics.
    Oliveira EJ; Watson DG
    Biomed Chromatogr; 2000 Oct; 14(6):351-72. PubMed ID: 11002274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalysis of recombinant proteins and antibodies by mass spectrometry.
    Ezan E; Dubois M; Becher F
    Analyst; 2009 May; 134(5):825-34. PubMed ID: 19381370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
    Wu ST; Ouyang Z; Olah TV; Jemal M
    Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
    Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel LC-MS approach for the detection of metabolites in DMPK studies.
    Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
    Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of biomarkers, drugs and toxins in biological samples by immunoaffinity chromatography coupled to mass spectrometry or tandem mass spectrometry: A focused review of recent applications.
    Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(2):133-48. PubMed ID: 19969510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.
    Ma S; Zhu M
    Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute quantitation of protein therapeutics in biological matrices by enzymatic digestion and LC-MS.
    Li F; Fast D; Michael S
    Bioanalysis; 2011 Nov; 3(21):2459-80. PubMed ID: 22074286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective quantification of chiral drugs in human plasma with LC-MS/MS.
    Liu K; Zhong D; Chen X
    Bioanalysis; 2009 Jun; 1(3):561-76. PubMed ID: 21083153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technologies and strategies to characterize and quantitate metabolites in drug discovery and development.
    Ravindran S; Jadhav A; Surve P; Lonsane G; Honrao P; Nanda B
    Biomed Chromatogr; 2014 Nov; 28(11):1547-53. PubMed ID: 25175001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic aspects of biotechnology products.
    Tang L; Persky AM; Hochhaus G; Meibohm B
    J Pharm Sci; 2004 Sep; 93(9):2184-204. PubMed ID: 15295780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.